Literature DB >> 12459193

The hypoxic core: a possible answer to the cancer paradox.

Michael Guppy1.   

Abstract

There are many differences, at all levels of organization, between cancerous and normal cells. Two of these (oxygen delivery and glucose metabolism) are related and manifest as low intercellular oxygen tensions (pO(2)) and a glycolytic metabolic profile in tumours and/or cancer cells. It is becoming increasingly apparent that these characteristics of cancer combine to enhance both the survival and aggressiveness of cancer cells, and that they can adversely impact on some forms of treatment. But they are also exploited in current strategies of detection and monitoring of cancers. These are therefore characteristics with important implications for the crucial balance between the aggression and growth characteristics of a tumour, and our ability to detect and treat it. The interactions and the hierarchy of events leading to these manifestations are complex, not fully understood, and involve a pivotal and intriguing paradox. This paradox results in a seemingly contradictory state in which the most dangerous tumours are those that are the most hypoxic, but also those that are the most angiogenic. This review is a synthesis of the available data into a feasible hypothesis which offers a possible resolution of this paradox and provides a testable paradigm for tumour behaviour.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459193     DOI: 10.1016/s0006-291x(02)02710-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.

Authors:  Lara Milane; Shanthi Ganesh; Shruti Shah; Zhen-Feng Duan; Mansoor Amiji
Journal:  J Control Release       Date:  2011-04-08       Impact factor: 9.776

2.  Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.

Authors:  Barbara Chiavarina; Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Agnieszka K Witkiewicz; Ruth Birbe; Anthony Howell; Richard G Pestell; Johanna Smith; Rene Daniel; Federica Sotgia; Michael P Lisanti
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

3.  Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.

Authors:  Donna S Dorow; Carleen Cullinane; Nelly Conus; Peter Roselt; David Binns; Timothy J McCarthy; Grant A McArthur; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

4.  Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.

Authors:  Lara Milane; Zhenfeng Duan; Mansoor Amiji
Journal:  Mol Pharm       Date:  2010-11-24       Impact factor: 4.939

Review 5.  Tumor metabolic reprogramming in lung cancer progression.

Authors:  Xin Li; Minghui Liu; Hongyu Liu; Jun Chen
Journal:  Oncol Lett       Date:  2022-06-28       Impact factor: 3.111

Review 6.  Multi-functional nanocarriers to overcome tumor drug resistance.

Authors:  Lara S Jabr-Milane; Lilian E van Vlerken; Sunita Yadav; Mansoor M Amiji
Journal:  Cancer Treat Rev       Date:  2008-06-05       Impact factor: 12.111

7.  The nanomechanical signature of breast cancer.

Authors:  Marija Plodinec; Marko Loparic; Christophe A Monnier; Ellen C Obermann; Rosanna Zanetti-Dallenbach; Philipp Oertle; Janne T Hyotyla; Ueli Aebi; Mohamed Bentires-Alj; Roderick Y H Lim; Cora-Ann Schoenenberger
Journal:  Nat Nanotechnol       Date:  2012-10-21       Impact factor: 39.213

8.  Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning.

Authors:  Lara Milane; Zhenfeng Duan; Mansoor Amiji
Journal:  Cancer Cell Int       Date:  2011-02-14       Impact factor: 5.722

9.  The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells.

Authors:  Dong-yun Shi; Fei-zhou Xie; Chao Zhai; Jeremy S Stern; Yang Liu; Shan-lin Liu
Journal:  Mol Cancer       Date:  2009-06-05       Impact factor: 27.401

10.  Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo.

Authors:  Ji-Young Jang; Yun Choi; Yoon-Kyung Jeon; Chul-Woo Kim
Journal:  Breast Cancer Res       Date:  2008-02-12       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.